Deletion of the c-src gene impairs osteoclast bone resorbing activity, causing osteopetrosis. Although it has been concluded that restoring only Src's adaptor function at least partly rescues the cell attachment and skeletal phenotypes, the contribution of 
INTRODUCTION
Targeted disruption of the src gene in mice induces osteopetrosis, a disorder characterized by decreased bone resorption, without showing any obvious morphological or functional abnormalities in other tissues or cells (1) . The osteopetrotic phenotype of src -/-mice is cell-autonomous and results from defects in mature osteoclasts, which normally express high levels of Src protein (2, 3) . The mobility of Src -osteoclasts is reduced by 60%, which is likely to account for at least some of the deficit in bone resorbing activity (4) . It remains uncertain, however, if catalytically active Src is required for normal osteoclast function. Some investigators have reported the genetic rescue of the src -/-osteopetrosis by kinase-deficient mutants of Src (5) . Together with the findings of Felsenfeld et al. that the adapter function of Src promotes fibroblasts motility (6) , these results suggest that the predominant role of Src in osteoclasts might be as an adaptor molecule, recruiting other proteins that are necessary for the modulation of integrin-cytoskeletal links, cell attachment and migration. On the other hand, there are reports that indicate that Src kinase activity is required for normal osteoclastic bone resorption (7) (8) (9) leaving the question of the contribution of Src kinase activity unsettled.
The identity of the Src target(s) in the signaling pathways that are required for normal osteoclast mobility and resorption also remains to be resolved. We previously reported that Cbl's basal phosphotyrosine content in osteoclasts is markedly Src-dependent, in contrast to several other known Src substrates (10) , and that Src forms an adhesion-induced complex with Cbl and the calcium-dependent tyrosine kinase Pyk2 in osteoclasts (4) . Replating Src + osteoclasts on vitronection receptor induced the phosphorylation of all three proteins, whereas only Pyk2 was phosphorylated in replated Src -/-osteoclasts, indicating that Src phosphorylates Cbl in this complex. In a reconstituted model system (HEK 293 cells transfected with the vitronection and Pyk2), Src kinase activity was required for adhesioninduced Pyk2-dependent tyrosine phosphorylation of Cbl (4) . However, we did not determine if the absence of Src kinase activity affected OC function in vitro.
We have therefore extended our investigation to examine the requirement for Src kinase activity in osteoclast function, taking advantage of the ability of adenoviral vectors to transduce foreign genes into osteoclasts (8, (11) (12) (13) . We found that both Src kinase activity and the Src SH2-dependent formation of the Pyk2/Src complex are required for bone resorption. Furthermore, we showed that inhibiting Src leads to a marked reduction in the phosphorylation of Y 731 in Cbl, the third component in the Py2-Src complex (4) , and that mutating Cbl Y 731 markedly inhibits bone resorption, possibly identifying Cbl as a key substrate of Src downstream of the Pyk2-Src complex in osteoclasts.
Infection of OCLs with adenovirus vectors was carried out following the method previously described (8) .
Cells and Cell Cultures
Mouse primary osteoblastic cells were obtained from 1-day-old mouse calvaria by enzymatic digestion, and bone marrow cells were from tibiae of 6-week-old Src +/? or Src -/-mice. Osteoblastic cells (5 x 10 5 cells/dish) were co-cultured with bone marrow cells (1 x 10 7 cells/dish) on 10 cm tissue culture dishes or collagen gel-coated dishes in the presence of 10 nM 1α, 25-dihydroxy vitamin D 3 and 1µM prostaglandin E 2 . For biochemical assays, osteoclast-like cells (OCLs) were purified as reported elsewhere (8) .
RAW 264.7 cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin and streptomycin. Prior to experiments, RAW264.7 cells were starved for 18 h in medium containing 0.1% FBS and treated with 10uM PP2 for 30 min.
Coimmunoprecipitation
Cell cultures were washed twice with ice-cold PBS and lysed in buffer containing 20 mM Hepes-NaOH (pH7.4), 150 mM NaCl, 0.05% NP-40, 10% glycerol, 10 mM EDTA, 1 mM Na 3 VO 4 , 10 µg/ml leupeptin, 10 µg/ml aprotinin, and 1 mM PMSF. After 30 min on ice, cell lysates were cleared by centrifugation at 12,000-x g for 20 min.
Immunoprecipitation was performed by incubating 500 µg of total cell lysate protein with 2 µg of antibody for 2 h on ice, then adding 20 µl of protein-G agarose. After incubation for 1 h at 4°C with end-over-end mixing, the immune complex was recovered by centrifugation and washed four times with buffer containing 20 mM Hepes-NaOH (pH7.4), 150 mM NaCl, 0.02% IGEPAL CA-630, 10 mM EDTA, 1 mM Na 3 VO 4 , 10 µg/ml leupeptin, 10 µg/ml aprotinin, and 1 mM PMSF. The immunoprecipitates were then subjected to SDS-PAGE and Western blotting.
In Vitro Kinase Assay
In vitro kinase activity was assayed as previously reported (8) . Briefly, Src immunoprecipitates were resuspended in 60 µl of kinase buffer (20 mM HEPES-NaOH, pH 7.4, and 10 mM MgCl 2 ) with 5 µCi of (γ-32 P) ATP in the presence of 1 µg of acidtreated enolase, then incubated for 20 minutes at 30°C. The reaction was stopped by adding 20 µl of 4 x sample buffer (250 mM Tris-HCl, pH 6.8, 8 mM EDTA, 12% SDS, 500 mM 2-mercaptoethanol, 15% glycerol, and 0.01% bromophenol blue). The samples were subjected to SDS-PAGE under reducing condition, followed by autoradiography.
Immunofluorescence Microscopy
For immunofluorescence analysis, cells were plated on sterile FBS-coated glass coverslips. OCLs were fixed in PBS containing 3.7% formaldehyde for 10 min, and then permeabilized with ice-cold acetone for 5 min. Coverslips for actin labeling were incubated in a 1:40 dilution (in PBS) of rhodamine phalloidin stock solution (Molecular Probes) for 20 min. Cells were sequentially stained with appropriate primary antibody followed by fluorescein-conjugated secondary antibody as previously reported (4). Cells were examined using a confocal imaging system (MRC-600; Bio-Rad Laboratories).
Pit Formation Assay
Functionally active OCLs were formed in co-cultures carried out on collagen gel as described elsewhere (8) . An aliquot of the crude OCL preparation was transferred onto dentine slices and cultured for an additional 12 h. The resorbed area was measured using an image analysis system linked to a light microscope (Osteometrics).
Survival of OCLs
The survival rate was measured as previously reported (12) . OCLs were purified 3 days after the infection and some of the cultures were subjected to tartrate-resistant 
Statistical Analysis
Each series of experiments was repeated at least three times. The results obtained from a typical experiment were expressed as the means ± standard deviation (SD).
Significant differences were determined using factorial analysis of variance (ANOVA).
RESULTS

Pyk2 Y402F overexpression inhibits the pit-forming activity of osteoclast-like cells
Pyk2 is highly expressed in the podosomes of osteoclasts (4, 15) and is autophosphorylated in response to integrin engagement (4) . To investigate the roles of Pyk2 kinase activity and the autophosphorylation of Pyk2 Y402 in osteoclast function, we constructed adenoviruses containing Xpress-tagged wild type Pyk2 (AxPyk2 WT ), autophosphorylation site-mutated Pyk2 (AxPyk2 Y402F ), or kinase-dead Pyk2 (AxPyk2 K457A ). We used a replication-deficient adenovirus vector that contains a reporter gene encoding GFP (AxGFP) as a control vector. The protein expression of the purified OCLs from cocultures infected with the recombinant viruses at different MOI's was examined after three days of infection by Western blotting with anti-Xpress antibody or anti-Pyk2 antibody. Equal amount of the three Pyk2 proteins were expressed in infected OCLs in a MOI-dependent manner (Fig. 1A ). Cells infected with AxPyk2 WT or AxPyk2 K457A exhibited in a single large actin ring similar to the ring seen in the cells infected with the control AxGFP. In contrast, Pyk2 Y402F -expressing OCLs contained actin patches and one or more small actin rings (Fig. 1B) .
Pyk2 Y402 is autophosphorylated following cell attachment and binds to Src's SH2 domain (4, 15, 16) . Consistent with these reports, endogenous Src bound to Xpress-tagged Pyk2 WT and Pyk2 K457A , but not to Pyk2 Y402F (Fig. 1C) . As expected, no phospho-Y 402 was detected in the cells expressing Pyk2 Y402F . In contrast, a low level of phosphorylation of the Y 402 of Pyk2 K457A was detected (Fig. 1D) , indicating either that this residue can be phosphorylated by some other kinase in osteoclasts, or that the small residual kinase activity of mutated Pyk2 is sufficient to catalyze a low level of phosphorylation.
To investigate the functional consequences of overexpressing Pyk2 WT , Pyk2 Y402F , or Pyk2 K457A , the bone resorbing activity of OCLs was quantified by measuring the areas of pits formed on dentine slices. As shown in Fig.1E , the pit-forming activity of OCLs was strongly inhibited in proportion to Pyk2 Y402F expression. In contrast, overexpression of Pyk2 WT or Pyk2 K457A had no effect on bone resorption. There was no significant difference in osteoclast survival among OCLs expressing the different Pyk2 proteins (data not shown). Thus, these data demonstrate that the interaction of Src with Pyk2, mediated by the SrcSH2 domain and the Pyk2 pTyr402, is required for the normal organization of the osteoclast actin cytoskeleton and for bone resorption.
The inhibitory effect of Pyk2 Y402F overexpression on bone resorption is not reversed by up-regulating Src kinase activity
The effect of overexpressing Pyk2 Y402F suggests that the recruitment of Src to autophosphorylated Pyk2 at adhesion sites is a key event in bone resorption, but it does not address the question of whether Src kinase activity is required or if the adaptor functions of Src's SH2 and SH3 domains are sufficient. Indeed, Schwartzberg and colleagues concluded from their in vivo results that the kinase activity of Src may be dispensable (5) . To address this question, we examined the effect of modulating Src kinase activity independently of the binding of Src to Pyk2. We first examined whether or not the up-regulation of Src kinase activity was sufficient to rescue the decreased pitforming activity of Pyk2 Y402F -expressing OCLs. For this purpose, we co-infected OCLs with AxPyk2 Y402F and adenovirus carrying kinase-dead C-terminal Src family kinase (AxCsk KD ), which prevents the phosphorylation of the negative regulatory Y 527 and increases Src kinase activity in OCLs (8) . Co-infected OCLs expressed Pyk2 Y402F
and Csk KD at levels similar to the cells infected with either Pyk2 Y402F or Csk KD alone ( Fig. 2A ). As shown in Fig. 2B , Src kinase activity in OCLs was up-regulated when Csk KD was overexpressed alone or when it was co-expressed with Pyk2 Y402F . The inhibitory effect of AxPyk2 Y402F on osteoclast function was, however, not rescued by co-infection with AxCsk KD (Fig. 2C) , indicating that high Src kinase activity alone is not sufficient to rescue the decreased bone resorbing activity in the Pyk2 Y402F -expressing OCLs and that the Pyk2-dependent recruitment of Src is necessary for bone resorption.
Src kinase activity is required for bone resorption
We then examined the role of Src kinase activity in situations where Pyk2- (Fig. 3B ). This morphology of Src K295M -expressing OCLs is similar to that of Src -/-OCLs (4). In addition, pit-forming activity was also inhibited, albeit never completely blocked, in proportion to the expression level of Src K295M protein (Fig. 3C) .
These results strongly suggest that it is the presence of the kinase activity of Src in the osteoclast adhesion structures, and not just the Src protein, that is necessary for actin ring formation and bone resorption. However, the autophosphorylation of Src promotes the adoption of the fully open active conformation (17, 18) , and thus Src K295M might not be an effective adaptor. To rule out the possibility that the dominant negative effects of Src K295M could be due to a loss of adaptor function, OCLs were infected with AxSrc K295M+Y527F , which prevents the phosphorylation of the negative regulatory Y 527 and promotes the availability of the SH2 and SH3 domains to bind other proteins. To ensure that the mutant Src proteins were indeed binding to Pyk2 in OCLs, the Src proteins were immunoprecipitated from OCLs lysates and the immune complexes were blotted to demonstrate the presence of Pyk2 (data not shown). The morphology and bone-resorbing activity of Src K295M+Y527F -expressing OCLs was similar to that of OCLs infected with AxSrc K295M (Fig. 3B and C) , indicating that it is the absence of kinase activity, not the possible failure to bind to Pyk2 and/or other proteins in the adhesion complex, that causes the loss of bone-resorbing activity.
To further confirm the importance of Src kinase activity, we investigated the functional changes in OCLs infected with AxSrc Y416F+Y527F . The Y416F mutation reduces kinase activity about 50% by preventing the phosphorylation of a tyrosine on the activation loop of Src (19, 20) . In spite of its open conformation, Src Y416F+Y527F partially inhibited osteoclast function, consistent with its reduced kinase activity.
AxSrc Y416F+Y527F -infected OCLs exhibited a few small actin rings (Fig. 3B) and still retained partial bone-resorbing activity (about 70 % of control) at an MOI of 100 (Fig. 3C) .
These results strongly suggest that the localization of catalytically active Src in adhesion structures is required for actin ring formation and bone resorption.
Src kinase activity is required for the efficient rescue of the Src -/-osteoclast phenotype
To further confirm the importance of Src kinase activity for osteoclastic bone resorption, and to determine the influence of endogenous Src levels in our previous experiments, we introduced Src mutants into Src -/-osteoclasts. As shown in Fig. 4A , the mutant Src proteins were expressed in infected Src -/-OCLs. Under these experimental conditions, Src -/-OCLs were completely unable to form resorption pits in our assay. Interestingly, Src K295M and Src K295M+Y527F , which did not notably affect the cytoskeletal organization of OCLs, restored, albeit extremely minimally (less than 3%), some bone-resorbing activity in Src -/-osteoclasts (p<0.001). This minimal effect could be due to the adaptor function of Src, or to the very low residual kinase activity in these mutants. In contrast, the expression of Src Y416F+Y527F , which retains about 50% kinase activity, induced the formation of actin rings and very significantly increased bone-resorbing activity to approximately 70% of control ( Fig. 4B and C) . These results clearly show that Src kinase activity is indeed required to rescue the disruptive effect of Src deficiency on the cytoskeletal organization and bone-resorbing activity of osteoclasts.
Identification of Src kinase-dependent signaling events
Having determined that both the Src adaptor function (binding to Pyk2) and Src kinase activity are required for bone resorption, we sought to identify downstream elements in Src-dependent signaling mechanism(s). We previously showed that Cbl is phosphorylated in a Src-dependent manner in osteoclasts and that bone resorption by OCLs in vitro is inhibited by both Src-and Cbl-specific antisense oligonucleotides (Fig. 5B) . Infection with AxCbl Y731F at an MOI of 100 inhibited pit formation by 70%, while AxCbl WT had no effect (Fig. 5C) . Thus, the Src-catalyzed phosphorylation of Cbl Y 731 appears to play an important role in the signaling leading to normal osteoclastic bone resorption.
Src kinase activity is not involved in osteoclast survival
We then determined whether Src kinase activity was also required for other functional aspects of the osteoclasts. The activation of Akt via a Src-dependent signaling pathway has been reported to be important for RANKL-induced osteoclast survival (9, 28) . On the other hand, the Ras/ERK signaling pathways also appears to be involved in osteoclast survival, since inhibiting ERK activity by overexpressing dominant negative Ras (Ras DN ) rapidly induces the apoptosis of OCLs, whereas activating ERK by overexpressing constitutively active MEK1 (MEK CA ) markedly reduces spontaneous apoptosis (12) . To examine the role of c-Src kinase in regulating osteoclast survival, we infected OCLs with AxSrc K295M , AxCsk WT , or AxCsk KD , either alone or together with AxMEK CA . The OCLs infected with AxMEK CA expressed Src K295M , Csk WT , or Csk KD proteins at similar levels as the cells without AxMEK CA (Fig. 6A) . Neither Src K295M , Csk WT , nor Csk KD had any effect on the survival of OCLs, regardless of whether the OCLs were infected with AxMEK CA (Fig. 6B and C) . More than 70% of OCLs infected with AxSrc K295M or AxCsk WT were still alive even 24 hours after purification when infected by AxMEK CA . These results indicate that c-Src kinase activity is important for cytoskeletal organization and bone resorption, but not for the survival of osteoclasts.
DISCUSSION
We have previously established that activating osteoclast vitronectin receptors by cross-linking or replating induces the formation of signaling complex that includes Pyk2, Src and Cbl (4). The primary goal of the present study was to determine if Pyk2-associated Src kinase activity is required for efficient osteoclast bone resorption or conversely, if the adaptor function of Src is sufficient to restore bone resorbing activity to Src -/-osteoclasts, as suggested by other investigators (5) . We demonstrate that both Src kinase activity and the localization of active Src to the complex via an interaction with Pyk2's phosphotyrosine 402 are essential for osteoclastic bone resorption, whereas Pyk2 kinase activity is not.
We first examined the importance of the binding of Src to Pyk2. The mutation of Pyk2 Tyr 402 inhibited both the Pyk2-Src interaction and bone resorption. In contrast, the kinase-dead Pyk2 K457A , which was phosphorylated on Tyr 402 , albeit to a lesser degree than the wild type Pyk2, bound Src and had little effect on bone resorption ( Fig. 1   C and D) . The phosphorylation of Tyr 402 of kinase-dead Pyk2 is likely catalyzed by another kinase, although a role for low residual kinase activity cannot be ruled out. While these and our earlier results suggested that recruitment of Src to adhesion structures is crucial in osteoclasts, as in other cell types (31), we also tested whether simply increasing Src kinase activity while preventing its binding to Pyk2 would affect bone resorption. The introduction of Csk KD failed to reverse the inhibitory effect of AxPyk2 Y402F on bone resorption (Fig. 2C) , further establishing that the formation of a Pyk2/c-Src complex occurs after integrin binding (4) but also that the formation of this complex is indispensable for osteoclastic bone resorption.
As noted earlier, the importance of Src kinase activity in bone resorption has been controversial. Schwartzberg et al., previously reported that osteoclast-specific expression of the kinase-dead Src K295M mutant partially restored normal trabecular bone volume and tooth eruption in the Src -/-mice and suggested that Src's key function in osteoclastic bone resorption might be as an adaptor molecule rather than tyrosine kinase (5) . On the other hand, others have reported that inhibiting Src kinase reduces bone resorption in vivo and in vitro (7, 8) and in the Schwartzberg study, Src kinase activity was required to restore the F-actin-rich ring of podosome attachment structures that is believed to be critically important for normal osteoclastic bone resorption. Thus, the central issue addressed by this study was the requirement for Src kinase activity in resorbing osteoclast. The data from our study clearly show that at the level of the individual osteoclast, the kinase activity of Src is indeed required for bone resorption.
Overexpressing kinase-dead Src K295M in OCLs that express endogenous c-Src disrupted actin ring formation, mimicking the cytoskeletal alterations observed in Src -/-osteoclasts, and strongly inhibited the pit-forming activity (Fig. 3C) . Furthermore, promoting the open conformation of Src by mutating Y 527 did not alter the inhibitory effect of Src K295M (Fig. 3C) , indicating that Src's adaptor function alone is not sufficient to support osteoclastic bone resorption. Overexpressing the partially active Src Y416F+Y527F mutant only partially inhibited the bone resorbing activity, further indicating need for full Src kinase activity in osteoclastic bone resorption.
These results were confirmed in Src -/-OCLs, where the potential interference of endogenously expressed Src is avoided. Most interestingly, while Src -/-OCLs were 100% devoid of resorbing activity, cells reconstituted with Src K295M demonstrated a very minimal (about 3%) but significant (p<0.001) level of pit forming activity (Fig. 4C) , which was still much less than the approximately 70% restoration of pit formation by OCLs reconstituted with Src Y416F+Y527F . This minimal restoration of activity by Src K295M suggests a possible explanation of the apparent discrepancy between our results with individual OCLs and Schwartzberg's findings in animals. It is known that there are several-fold more osteoclasts in Src -/-than in wild type animals, and the degree of osteopetrosis in these animals is moderate (32) . Even a small increase in the activity of the larger number of osteoclasts acting over a longer time than our in vitro bone resorbing assay could induce sufficient additional bone resorption to account for the partial rescue reported by Schwartzberg and colleagues (5). Schwartzberg et al. did not note the time required for tooth eruption, which might be longer in the mice expressing the mutant Src proteins. It should also be noted that the Schwartzberg study found that Src Y416 rescued the osteopetrotic phenotype more efficiently than Src K295M . This is consistent with our findings that both Src's adaptor function, which allows Src to be properly recruited to Pyk2 at the adhesion sites, and Src kinase activity are indispensable for efficient cytoskeletal organization and osteoclastic bone resorption.
Elucidation of the role of Src in OC function requires the identification of the signaling elements whose activities might to be modulated by the recruitment of active Src kinase to Pyk2. We previously reported that the tyrosine phosphorylation of Cbl appears to be particularly dependant on the presence of Src (10) . Others have reported that Src phosphorylates CblY 731 (33) creating a binding site for the regulatory p85 subunit of PI3-K (22, 24) . PI3-K in turn is involved in a reorganization of the cytoskeleton that results in cell spreading and migration of several cell types. In osteoclast PI3-K activity is important for osteoclast activity (25) . Our confirmation that Src catalyzes the phosphorylation of CblY 731 and demonstration that the mutation of that residue to phenylalanine, thereby preventing the Src-catalyzed phosphorylation inhibits bone resorption further supports our previous suggestion that Cbl is important substrate of Src in osteoclasts and focus our attention on PI3-K as a likely downstream effector of the Pyk2/Src/Cbl complex.
Src-dependant Akt activation is important for RANKL-induced osteoclast survival (28) , and Schwartzberg and colleagues reported that the expression of Src251, a truncated Src molecule that lacks the kinase domain, decreases Akt activity and osteoclast survival in transgenic mice (9) . We therefore considered whether the requirement for Src kinase activity could be related to the regulation of osteoclast survival. Src can also contribute to the activation of Ras/ERK signaling pathway (34, 35) , which has also been implicated in promoting osteoclast survival. However, our finding that down-regulation of c-Src kinase activity had no effect on the survival of OCLs, together with the fact that there is no significant difference between the survival of wild type OCLs and c-Src -/-OCLs (28) suggests that Src makes little contribution to enhancing the survival of osteoclasts.
In conclusion, our study demonstrates that both the formation of a Pyk2/Src complex, presumably in the podosomes, and the kinase activity of Src are required for bone resorption by osteoclasts. Src kinase activity may be required in part to phosphorylate Cbl, thereby creating a binding site for PI3-K and recruiting it to the Pyk2/Src/Cb complex. These results provide further insight into how the attachment of osteoclasts to the bone surface regulates bone resorption and how Src participates in this regulation. AxCsk KD and AxPyk2 Y402F was measured as described in Fig. 1E . The values are means ± SD (n=8; *p<0.05, ** p<0.01 compared to AxGFP-infected OCLs). 
